Pharmacology:
Urispas is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Urispas is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.Urispas for patients
Patients should be informed that if drowsiness and blurred vision occur, they should not operate a motor vehicle or machinery or participate in activities where alertness is required.
Urispas Interactions
No information provided.
Urispas Contraindications
Urispas (flavoxate HCl) is contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.
Additional information about Urispas
Urispas Indication: For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.Mechanism Of Action: Urispas acts as a direct antagonist at muscarinic acetylcholine receptors in cholinergically innervated organs. Its anticholinergic-parasympatholytic action reduces the tonus of smooth muscle in the bladder, effectively reducing the number of required voids, urge incontinence episodes, urge severity and improving retention, facilitating increased volume per void.
Drug Interactions: Donepezil Possible antagonism of action
Galantamine Possible antagonism of action
Rivastigmine Possible antagonism of action
Food Interactions: Take without regard to meals.
Food may reduce irritation.
Generic Name: Flavoxate
Synonyms: Flavoxate HCI; Flavoxate HCL
Where to order Flavoxate (and Urispas analogs) online:
Drug Category: Parasympatholytics
Drug Type: Small Molecule; Approved
Other Brand Names containing Flavoxate: Urispas;
Absorption: Well absorbed from gastrointestinal tract.
Toxicity (Overdose): The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Urispas: Tablet Oral
Chemical IUPAC Name: 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate
Chemical Formula: C24H25NO4
Flavoxate on Wikipedia: http://en.wikipedia.org/wiki/Flavoxate
Organisms Affected: Humans and other mammals
Bookmark or Share this page
Search by name browsing our [A-Z] index:
Search by Categories:
- Gastric acid regulation
- Allergy / Asthma sprays and inhalers
- Antidepressants and Antianxiety
- Antidiabetic drugs
- Anti-fungus meds
- Herpes treatment
- Antibiotics
- Very popular
- Blood Pressure / High Cholesterol level
- General Health pills
- Bone treatment
- Drugs for Men (Sexual health)
- Pain relievers / Muscle Relaxers
- Pets meds
- Skin Care
- Sleeping pills&strips
- Quit Smoking
- Weight Loss pills
- Drugs for Women
See a list of all drugs for sale »
Visit our partners:

